Fumiko Esashi

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Transcription Factor

Circulating Tumor

Top Venues

The EMBO journal

Wellcome open research

Proceedings of the National Academy of Sciences of the United States of America

Cancer Research UK

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Cancer Research UK

United Kingdom

Postdoctoral researcher :: Clare Hall Laboratories

Publications

Marjorie Fournier, Amélie Rodrigue, Larissa Milano, Jean-Yves Bleuyard, Anthony M Couturier, Jacob Wall, Jessica Ellins, Svenja Hester, Stephen J Smerdon, Làszlò Tora, Jean-Yves Masson, Fumiko Esashi
KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity. eLife 11 (2022)
Xanita Saayman, Fumiko Esashi
Breaking the paradigm: early insights from mammalian DNA breakomes. The FEBS journal (2021)
Isabel E Wassing, Emily Graham, Xanita Saayman, Lucia Rampazzo, Christine Ralf, Andrew R Bassett, Fumiko Esashi
The RAD51 recombinase protects mitotic chromatin in human cells. Nature communications 12 (1) (2021)
Federico Paoletti, Afaf H El-Sagheer, Jun Allard, Tom Brown, Omer Dushek, Fumiko Esashi
Molecular flexibility of DNA as a key determinant of RAD51 recruitment. The EMBO journal 39 (7) (2020)
Jean-Yves Bleuyard, Marjorie Fournier, Ryuichiro Nakato, Anthony M Couturier, Yuki Katou, Christine Ralf, Svenja S Hester, Daniel Dominguez, Daniela Rhodes, Timothy C Humphrey, Katsuhiko Shirahige, Fumiko Esashi
MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress. Proceedings of the National Academy of Sciences of the United States of America 114 (29) (2017)
Jean-Yves Bleuyard, Rosie M Butler, Fumiko Esashi
Perturbation of PALB2 function by the T413S mutation found in small cell lung cancer. Wellcome open research 2 (2017)